Showing results (721-730 of 3,703) with videos related to
Sort By:
Pageof 371
Pharmacology & Therapeutics|September 22, 2020
The strategies and techniques of drug discovery from natural productsLi Zhang, Junke Song, Linglei Kong, et al.Pharmacology & Therapeutics|September 22, 2020
Tubulin modifying enzymes as target for the treatment of tau-related diseasesKrzysztof Rogowski, Khaled Hached, Carole Crozet, et al.Pharmacology & Therapeutics|November 4, 2020
Targeting post-translational histone modifying enzymes in glioblastomaElena Kunadis, Eleftheria Lakiotaki, Penelope Korkolopoulou, et al.Pharmacology & Therapeutics|April 29, 2022
Comprehensive insights in GRK4 and hypertension: From mechanisms to potential therapeuticsJian Yang, John E Hall, Pedro A Jose, et al.Pharmacology & Therapeutics|January 1, 1985
Changes in deoxynucleoside triphosphate pools induced by inhibitors and modulators of ribonucleotide reductaseR M FoxPharmacology & Therapeutics|October 19, 2019
Relevance of the antioxidant properties of methotrexate and doxycycline to their treatment of cardiovascular diseaseDahn L Clemens, Michael J Duryee, Johnathan H Hall, et al.Pharmacology & Therapeutics|July 25, 2022
Chloride channels in the lung: Challenges and perspectives for viral infections, pulmonary arterial hypertension, and cystic fibrosisMadhushri Sinha, Diana Zabini, Divya Guntur, et al.Pharmacology & Therapeutics|July 25, 2022
Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment optionsJae Young So, Joyce Ohm, Stan Lipkowitz, et al.Pharmacology & Therapeutics|July 28, 2022
Recent advances in metabolism and toxicity of tyrosine kinase inhibitorsQi Zhao, Zhanxuan E Wu, Bin Li, et al.Pharmacology & Therapeutics|July 29, 2022
Current and emerging therapies for neuroendocrine prostate cancerBusola Ruth Alabi, Shiqin Liu, Tanya StoyanovaPageof 371